Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Jan
18
2022
“Show More of You”: Amgen v. Sandoz, Battling it Out on Amgen’s Otezla® Drug Finnegan
Jun
25
2021
Do What You Learned in Kindergarten: Fight Fair and Play by the Rules—Avoiding Litigation Misconduct Finnegan
Jan
3
2022
The Virtues of Claiming Precisely What the FDA Approved! Finnegan
Sep
22
2021
Predictably Part 2: Merck Overcomes Obviousness Challenge at the PTAB Finnegan
Nov
3
2021
Whiskey’s Good Proofing Water, But It Doesn’t Tell You Who the Real Peaky Blinders Are Finnegan
Feb
11
2022
Panel Rejects Status Quo Arguments and Upholds Injunction Finnegan
Sep
8
2021
Withheld Prior Art and Inconsistent Arguments Used to Obtain FDA Approval Renders Patent Unenforceable Finnegan
Nov
29
2021
Federal Circuit Disinfects PTAB’s Obviousness Finding for MRSA Inactivation Patent Finnegan
Jun
30
2023
"High" Risk, It's Inevitable Ankura
Jun
30
2023
The State of the Market for Cannabis Ankura
Sep
22
2021
Law of the Land - Real Estate Litigation Newsletter (September 22, 2021) Goulston & Storrs
Jun
6
2022
New Prohibition of Vapes and Electronic Cigarettes in Mexico OLIVARES
Apr
27
2023
Digitalization of Procedures for Cosmetic Products OLIVARES
Jan
18
2022
New Guidelines for Good Manufacturing Practices Concerning Medical Devices in Mexico OLIVARES
Jan
25
2023
Further Restrictions on Food and Drink Labeling OLIVARES
Dec
10
2021
Mexico: The Supreme Court of Justice Authorized the Industrial Use of Cannabis. OLIVARES
Jul
15
2022
In Mexico, a Reform Project Is Being Discussed That Contains Restrictive Measures for the Advertising and Marketing of Products Containing Tobacco OLIVARES
Feb
22
2024
Regulatory Certainty for Biosimilars in Mexico OLIVARES
Feb
21
2022
The Era of Digitization: The Mexican Sanitary Agency, COFEPRIS. OLIVARES
Apr
19
2023
Mexico Tests the Notice Requirement Pursuant to Patent Linkage Regulation OLIVARES
Jul
13
2022
Mexico Issues New NOM for Good Manufacturing Practices (GMP) Regarding Cosmetic Products. OLIVARES
Apr
19
2023
Cofepris Will Investigate the 63 Cannabis Permits Granted in Mexico Back on 2018 OLIVARES
Aug
16
2023
COFEPRIS Secure Cannabis Based Products. OLIVARES
Jun
8
2021
Mexico Amends the Health Law Regulations with Impact in the Approval of Medicines OLIVARES
Jul
6
2021
The Supreme Court of Justice Authorized the Recreational Use of Cannabis OLIVARES
Jul
28
2022
The Trials & Tribulations of Mass Torts Tribeca Lawsuit Loans
Aug
10
2022
FDA Issues Draft Guidance on Diversity and Inclusion in Clinical Trials Phillips Lytle LLP
Oct
13
2023
Alive and Well: Daubert Challenges Based on an Expert’s Lack of Qualifications Phillips Lytle LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins